.svg)
.svg)
Ascendia Pharmaceuticals®, a leading specialty CDMO with a decade of proven formulation solutions, is excited to announce its attendance at Contract Pharma's 2023 Contracting and Outsourcing Conference and Tabletop Exhibition in New Brunswick.
By Robert Bloder
The event, taking place from September 21st-22nd, hits on all you need to know with easy, informal discussions on manufacturing, packaging, laboratory services and more. Ascendia's participation in this conference highlights its commitment to solving complex formulation challenges associated with a variety of delivery methods and offerings to yield the cutting-edge solutions to pharmaceutical companies working with all dosage forms.
Visit Ascendia Pharmaceuticals® at Table #142 to discover how our BEST philosophy and experienced team of scientists can bring your project from formulation through to commercialization. Our nanotechnologies and state-of-the-art manufacturing facility have made us a Partner of Choice for many customers.
Why Visit Ascendia®
Visitors to Ascendia Pharmaceuticals’ table will learn how Ascendia has established itself as a frontrunner in the pharmaceutical CDMO industry. Ascendia's offers enabling platform technologies and a track record of providing solutions for unmet medical needs. By attending this event, Ascendia plans to connect with industry professionals seeking innovative formulation solutions that enhance persistence, compliance, and overall patient outcomes.
Contract Pharma's 2023 Contracting and Outsourcing Conference and Tabletop Exhibition serves as an ideal platform for Ascendia to highlight its capabilities and expertise in the field of controlled release technologies. Ascendia specializes in achieving optimal bioavailability, solubility, and stability - the three key factors crucial for a successful controlled release product.
Whether it's sterile or non-sterile products, oral solids, injectables, vaccines, or gene therapy, Ascendia's proficiency covers a wide range of formulation expertise across all modalities.
Ascendia Pharmaceuticals has a strong focus on lipid nanoparticles (LNPs), which play a vital role in advanced drug delivery systems. Ascendia is proud to be the only CDMO in North America equipped with the three essential LNP equipment for development, optimization, and GMP manufacturing. This unique advantage ensures continuity, consistency, and reliable results throughout the formulation and manufacturing processes, which is critical for successful controlled release product launch into market.
Schedule a meeting with us during the show
Don't miss the opportunity to connect with Ascendia Pharmaceuticals' executive leadership team at the Contracting and Outsourcing Conference and Tabletop Exhibition to learn about our expertise and technologies. More specifically, Ascendia's expertise in providing innovative formulation solutions, especially in LNP technology, sets it apart as a leader in the industry. Visit Table #142 to explore how Ascendia can help you overcome formulation challenges and optimize your product development from pre-formulation development and clinical to commercialization .
Reach out to Ascendia during the conference to start a conversation about your project and unlock the potential for success. You can also contact us to schedule a visit.
